EMA adopts EU Ombudsman recommendations to avoid bias concerns over drug approvals

26 November 2019 - Seeking to end another flap about transparency, the European Medicines Agency has agreed to recommendations made ...

Read more →

European Medicines Agency is advised to take steps to avoid bias concerns over approvals

22 July 2019 - Following a two-year inquiry, the European Ombudsman has recommended the European Medicines Agency take several steps ...

Read more →

EU Ombudsman confirms EMA’s correct handling of declared interests

24 November 2017 - Latest decision concludes no maladministration at EMA. ...

Read more →